Pinto Inc.

CULVER CITY, CA · Founded 2024 · CIK 0002088134 · Biotech · Acquired

Regenerative medicine therapies for pain relief targeting underlying tissue damage

pinto.health →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$20K
1 Form D · Oct 2025
12 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$20,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1487Selva Nexus, Inc.—$50K
1488NOVOBIOTIC PHARMACEUTICALS, LLC——
1489Cellevate Inc.—$25K
1490Pinto Inc.—$20K
1491CERACUITY, INC.—$3K
1492ProtaBody, Inc.—$800
1493SynPhaGen, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Gustavo CastilloDirector · Executive Officer
  • Kyle GillespieExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.